Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Am J Obstet Gynecol. 2012 Apr;206(4):311.e1–311.e9. doi: 10.1016/j.ajog.2012.02.002

Table 3.

Maternal and neonatal outcomes of the matched cohort, stratified by approach to delivery.

Outcome ERCD N = 3981 N (%) TOL N = 3981 N (%) P-valuea Conditional OR (95% CI)

Maternal
 Endometritis 85 (2.1) 144 (3.6) <.001 0.57 (0.43 – 0.75)
 Wound complication 34 (0.9) 17 (0.4) 0.02 2.00 (1.12 – 3.58)
 Operative injury 6 (0.2) 20 (0.5) 0.006 0.30 (0.12 – 0.75)
 Hysterectomy 12 (0.3) 3 (0.1) 0.02 4.00 (1.13 – 14.17)
 Maternal compositeb 136 (3.4) 200 (5.0) <.001 0.67 (0.53 – 0.83)
Neonatal
 TTN 119 (3.0) 107 (2.7) 0.41 1.12 (0.86 – 1.46)
 RDS 41 (1.0) 68 (1.7) 0.01 0.60 (0.41 – 0.89)
 Infection 124 (3.1) 211 (5.3) <.001 0.58 (0.46 – 0.72)
 Acidemia 14 (0.4) 25 (0.6) 0.08 0.56 (0.29 – 1.08)
 Neonatal death 1 (0.03) 2 (0.05) 0.56 0.50 (0.05 – 5.51)
 Neonatal compositec 202 (5.1) 295 (7.4) <.001 0.67 (0.55 – 0.80)

ERCD, elective repeat cesarean; TOL, trial of labor; OR, odds ratio; CI, confidence interval; TTN, transient tachypnea of the newborn; RDS, respiratory distress

a

P-value from McNemar's test

b

Maternal composite outcome includes uterine rupture, endometritis, wound complication, operative injury, hysterectomy, thromboembolism or maternal death.

c

Neonatal composite outcome includes TTN, RDS, infection, acidemia, neonatal death or hypoxic ischemic encephalopathy.